Monash will work with Ulvac to develop cutting-edge fabrication technologies with a particular focus on medical diagnostics and related biomedical fields. These research areas are dependent on the ability to manipulate structures a fraction of a human hair in size - the combination of Monash's research prowess, Ulvac's expertise, and MCN's facility is envisaged to improve the understanding required to do this. "The agreement demonstrates the ability of the Monash Platforms Network and the world-leading nanotechnology facilities available in the area such as MCN to attract international and established business opportunities, while also reiterating Ulvac's long-standing commitment to the Australian research community," said Professor Nico Voelcker, Scientific Director at the MCN.
展开▼
